ArticleInternational journal of immunopathology and pharmacology

Subcutaneous immunoglobulin replacement therapy in a patient with 18q deletion syndrome, primary immune deficiency, and type 1 diabetes.

Anna Hogendorf et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.